ANI Pharmaceuticals SVP Sells $357,470 in Stock as Shares Trade Below Sale Price
Thomas Andrew Rowland, senior vice president and head of established brands at ANI Pharmaceuticals, sold 4,772 shares on March 11, 2026, for $74.91 per share, totaling $357,470. The company recently reported a better-than-expected fourth quarter of 2025, yet the stock was trading below the sale price and experienced a premarket decline. Independent…